Trial
NCT00028652
Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Wisconsin, Madison
Collaborators
National Cancer Institute (NCI)
Condition
Metastatic Cancer
Intervention
interleukin-12 gene
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-13